BMIAX
Price
$7.13
Change
-$0.09 (-1.25%)
Updated
Feb 21 closing price
Net Assets
179.71M
RMFCX
Price
$57.23
Change
-$0.62 (-1.07%)
Updated
Feb 21 closing price
Net Assets
105.48B
Ad is loading...

BMIAX vs RMFCX

Header iconBMIAX vs RMFCX Comparison
Open Charts BMIAX vs RMFCXBanner chart's image
BNY Mellon Income Stock A
Price$7.13
Change-$0.09 (-1.25%)
VolumeN/A
Net Assets179.71M
American Funds American Mutual R3
Price$57.23
Change-$0.62 (-1.07%)
VolumeN/A
Net Assets105.48B
BMIAX vs RMFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
BMIAX vs. RMFCX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMIAX is a StrongBuy and RMFCX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 105B vs. BMIAX (180M). RMFCX (1.69) and BMIAX (1.69) have matching dividends . BMIAX was incepted earlier than RMFCX: BMIAX (9 years) vs RMFCX (23 years). BMIAX is a more actively managed with annual turnover of: 83.54 vs. RMFCX (25.00). RMFCX has a lower initial minimum investment than BMIAX: RMFCX (250) vs BMIAX (1000). RMFCX annual gain was more profitable for investors over the last year : 11.03 vs. BMIAX (-2.54). RMFCX return over 5 years is better than : 41.75 vs. BMIAX (-12.33).
BMIAXRMFCXBMIAX / RMFCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence9 years23 years-
Gain YTD4.7594.83698%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets180M105B0%
Annual Yield % from dividends1.691.69100%
Returns for 1 year-2.5411.03-23%
Returns for 3 years-19.4919.69-99%
Returns for 5 years-12.3341.75-30%
Returns for 10 yearsN/A64.83-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EVRI13.810.01
+0.07%
Everi Holdings
YETI36.83-0.08
-0.22%
YETI Holdings
GNFT3.83-0.09
-2.30%
Genfit SA
CTXR1.80-0.05
-2.70%
Citius Pharmaceuticals Inc
AER101.67-4.11
-3.89%
Aercap Holdings NV